Tempest Therapeutics, Inc. (TPST)
USD 0.7
(-11.57%)
USD 0.7
(-11.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 381 Thousand | 1.81 Million | 1.27 Million | 815 Thousand | 1.05 Million | 32 Thousand |
| Gross Profit | -381 Thousand | -1.81 Million | -1.27 Million | -815 Thousand | -1.05 Million | -32 Thousand |
| Operating Expenses | 29.15 Million | 34.64 Million | 26.98 Million | 19.29 Million | 44.34 Million | 23.08 Million |
| Selling, General and Administrative Expenses | 11.65 Million | 12.11 Million | 9.82 Million | 4.9 Million | 16.5 Million | 8.65 Million |
| Research and Development Expenses | 17.49 Million | 22.52 Million | 17.16 Million | 14.38 Million | 27.84 Million | 14.42 Million |
| Other Expenses | - | 549 Thousand | -34 Thousand | - | - | - |
| Cost and Expenses | 29.15 Million | 34.64 Million | 26.98 Million | 19.29 Million | 45.39 Million | 23.11 Million |
| Operating Income | -29.15 Million | -34.64 Million | -26.98 Million | -19.29 Million | -45.39 Million | -23.11 Million |
| Interest Expense | 1.44 Million | 1.61 Million | 1.28 Million | - | - | 134 Thousand |
| Income Tax Expense | - | 1.06 Million | 1.24 Million | -90 Thousand | 1000.00 | -169 Thousand |
| Earnings before Tax | -29.49 Million | -35.7 Million | -28.3 Million | -19.2 Million | -44.56 Million | -27.17 Million |
| Net Income | -29.49 Million | -36.77 Million | -29.55 Million | -19.11 Million | -44.56 Million | -27.19 Million |
| Earnings Per Share Basic | -1.91 | -3.18 | -7.80 | -612.56 | -48.77 | -263.65 |
| Earnings Per Share Diluted | -1.91 | -3.18 | -7.80 | -612.56 | -48.77 | -263.65 |
| Weighted Average Shares Outstanding | 15.41 Million | 11.54 Million | 3.79 Million | 31.21 Thousand | 913.78 Thousand | 103.13 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 15.41 Million | 11.54 Million | 3.79 Million | 31.21 Thousand | 913.78 Thousand | 103.13 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -28.77 Million | -32.27 Million | -25.71 Million | -18.39 Million | -43.51 Million | -27.01 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 155 Thousand | 88 Thousand | 381 Thousand | 85 Thousand | 510 Thousand | 497 Thousand |
| Gross Profit | -155 Thousand | -88 Thousand | -381 Thousand | -85 Thousand | -510 Thousand | -497 Thousand |
| Operating Expenses | 9.42 Million | 7.88 Million | 28.77 Million | 7.42 Million | 6.59 Million | 7.47 Million |
| Selling, General and Administrative Expenses | 3.59 Million | 3.54 Million | - | 3.24 Million | 2.37 Million | 3.05 Million |
| Research and Development Expenses | 5.83 Million | 4.34 Million | - | 4.18 Million | 4.22 Million | 4.41 Million |
| Other Expenses | - | - | - | -697 Thousand | 179 Thousand | - |
| Cost and Expenses | 9.58 Million | 7.97 Million | 29.15 Million | 7.51 Million | 6.59 Million | 7.47 Million |
| Operating Income | -9.58 Million | -7.97 Million | -29.15 Million | -7.51 Million | -6.59 Million | -7.47 Million |
| Interest Expense | 372 Thousand | 368 Thousand | 1.44 Million | 377 Thousand | -373 Thousand | 355 Thousand |
| Income Tax Expense | - | 44.72 Thousand | - | -472 Thousand | -88 Thousand | 161 Thousand |
| Earnings before Tax | -9.57 Million | -7.9 Million | -29.49 Million | -7.48 Million | -6.78 Million | -7.58 Million |
| Net Income | -9.57 Million | -7.9 Million | -29.49 Million | -7.48 Million | -6.78 Million | -7.58 Million |
| Earnings Per Share Basic | -0.42 | -0.36 | - | -0.35 | -0.48 | -0.54 |
| Earnings Per Share Diluted | -0.42 | -0.36 | - | -0.35 | -0.48 | -0.54 |
| Weighted Average Shares Outstanding | 22.54 Million | 22.23 Million | 15.41 Million | 21.52 Million | 14.12 Million | 14.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.54 Million | 22.23 Million | 15.41 Million | 21.52 Million | 14.12 Million | 14.1 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -9.42 Million | -7.88 Million | - | -7.42 Million | -6.59 Million | -7.22 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
8957
ISUR
600572
301007
ITCFY
III